Affiliation:
1. School of Medicine, Chongqing University, Chongqing 400030, China
2. Department of Hematology-Oncology, Chongqing University Cancer Hospital, Chongqing 400030, China
Abstract
In the era of antiretroviral therapy (ART), mortality among people living with the human immunodeficiency virus (HIV) has significantly decreased, yet the population of people living with HIV remains substantial. Among people living with HIV (PLWH), HIV-associated lymphoma (HAL) has surpassed Kaposi’s sarcoma to become the most common tumor in this population in developed countries. However, there remains a dearth of comprehensive and systematic understanding regarding HIV-associated lymphomas. This review aims to shed light on the changes in the immune system among PLWH and the characteristics of the immune microenvironment in HIV-associated lymphoma, with a specific focus on the immune system’s role in these individuals. Additionally, it seeks to explore recent advancements in immunotherapy for the treatment of HIV-associated lymphoma, intending to enhance strategies for immunotherapy in this specific population.
Funder
Natural Science Foundation of Chongqing, China
Fundamental Research Funds for the Central Universities
Chongqing Professional Talents Plan
Reference94 articles.
1. Hematologic cancers in individuals infected by HIV;Carbone;Blood,2022
2. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms;Alaggio;Leukemia,2022
3. Isaguliants, M., Bayurova, E., Avdoshina, D., Kondrashova, A., Chiodi, F., and Palefsky, J.M. (2021). Oncogenic Effects of HIV-1 Proteins, Mechanisms Behind. Cancers, 13.
4. High expression of HIV-1 matrix protein p17 in both lymphoma and lymph node tissues of AIDS patients;Feng;Pathol. Res. Pract.,2022
5. Expression of HIV-1 matrix protein p17 and association with B-cell lymphoma in HIV-1 transgenic mice;Carroll;Proc. Natl. Acad. Sci. USA,2016